Health Catalyst (HCAT) Stock: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$1.74
-0.01 (-0.57%)
▼
5d:
+0.0%
30d:
-7.94%
90d:
-13.43%
BUY
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HCAT shows positive signals but monitor for confirmation. Market pricing in 65.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: HCAT shows positive signals but monitor for confirmation. Market pricing in 65.4% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $1.74, which is considered fair relative to its 30-day fair value range of $1.72 to $1.80. From a valuation perspective, the stock is trading at a premium (Forward PE: 232.0) compared to its historical average (51.2). At these levels, the market is pricing in 65.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a downtrend. Immediate support is located at $1.65, while resistance sits at $1.84.
Market Sentiment: HCAT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HCAT is in a downtrend. Immediate support is located at $1.65, while resistance sits at $1.84.
Market Sentiment: HCAT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.72 -
$1.80
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($1.77)
- BEARISH: Market expects 65.4% growth - appears too optimistic based on history
- BULLISH: Bottoming setup score 65/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.72 -
$1.80
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.65
Resistance Level
$1.84
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
232.00
Wall Street Target
$1.77
(+1.5%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-90.6%
Valuation Premium vs History
+65.4% premium
PE vs Historical
232.0 vs 51.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+65.4%
(market-implied from PE analysis)
1-Year Target
$2.61
(+50%)
2-Year Target
$3.92
(+125%)
3-Year Target
$5.87
(+238%)
3-Yr Target (if PE normalizes)
(PE: 232→51)
PE COMPRESSION
$1.30
(-26%)
Significant PE compression expected
Share & Embed Analysis
Last updated: October 22, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 30 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$79 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 33 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 40 SELL |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$112 | 39 SELL |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
